Acidum Oxalicum-Injeel Liq (D12-D200) 12 D Liquid is a Health Canada–registered human drug (DIN 02037262) held by Biologische Heilmittel Heel GmbH, containing Oxalic Acid. Health Canada lists its status as Cancelled Post Market (status date 05 Mar 1997). Nexara Health has matched 10 registrations of Oxalic Acid across 5 other regulated markets.
Health Canada registration
| DIN | 02037262 |
|---|---|
| Brand name | Acidum Oxalicum-Injeel Liq (D12-D200) |
| Active ingredient | Oxalic Acid |
| Strength | 12 D |
| Dosage form | Liquid |
| Route | Oral |
| Company | Biologische Heilmittel Heel GmbH |
| Status | Cancelled Post Market — 05 Mar 1997 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Oxalic Acid registered in other markets
10 registrations of the same molecule in 5 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| European Union (EMA) | Dany's BienenWohl | — | Authorised | EMA centrally authorised | ||
| European Union (EMA) | Oxybee | — | Authorised | EMA centrally authorised | ||
| Finland | Dany's BienenWohl | Dany Bienenwohl GmbH | 39.4 mg/ml | Jauhe ja liuotin dispersiota varten, mehiläispesään | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Oxybee | Dany Bienenwohl GmbH | 39.4 mg/ml | Jauhe ja liuotin dispersiota varten, mehiläispesään | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Poland | Dany’s BienenWohl | Dany Bienenwohl GmbH | 39,4 mg/ml | Proszek i roztwór do sporządzania zawiesiny | URPL RPL | |
| Poland | Oxybee | Dany Bienenwohl GmbH | 39,4 mg | Proszek i roztwór do sporządzania zawiesiny | URPL RPL | |
| Taiwan | Oxalic Acid Reagent | Eli. Lilly & Co. | （粉） | 已註銷 | TFDA | |
| United States | Oxalicum acidum | Boiron | Pellet | listed | FDA NDC | |
| United States | Oxalicum acidum | Boiron | Pellet | listed | FDA NDC | |
| United States | Oxalicum Acidum | Boiron | Pellet | listed | FDA NDC |
See every manufacturer of Oxalic Acid worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Acidum Oxalicum-Injeel Liq (D12-D200) (DIN 02037262) marketed in Canada?
No. Health Canada lists DIN 02037262 as Cancelled Post Market as of 05 Mar 1997.
Who holds the Canadian licence for this product?
Biologische Heilmittel Heel GmbH is the company of record in the Health Canada Drug Product Database.
Is Oxalic Acid registered outside Canada?
Yes — Nexara Health has matched 10 registrations in 5 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02037262, status date 1997-03-05; national medicine registries: EMA centrally authorised, FDA NDC, Fimea Perusrekisteri, TFDA, URPL RPL. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02037262, status date 1997-03-05; national medicine registries: EMA centrally authorised, FDA NDC, Fimea Perusrekisteri, TFDA, URPL RPL.
Health Canada Drug Product Database (DPD), DIN 02037262, status date 1997-03-05; national medicine registries: EMA centrally authorised, FDA NDC, Fimea Perusrekisteri, TFDA, URPL RPL. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.